<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800035/" ref="ordinalpos=946&amp;ncbi_uid=5466459&amp;link_uid=PMC3800035" image-link="/pmc/articles/PMC3800035/figure/pone-0076895-g007/" class="imagepopup">Figure 7. Schematic representation of differential utilization of co-receptors and G-proteins for β-catenin-dependent and β-catenin-independent <span class="highlight" style="background-color:">signaling</span> pathways..  From: Heterotrimeric G-Protein, Gα16, Is a Critical Downstream Effector of Non-Canonical Wnt <span class="highlight" style="background-color:">Signaling</span> and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer. </a></div><br /><div class="p4l_captionBody">Based on our current understanding of Wnt-sensitive pathways, we propose that Wnt binding to Fzd and co-receptor LRP5/6, and mediated by Gαo, leads to activation of β-catenin-dependent gene transcription. While, Wnt binding to Fzd and co-receptor ROR1/2, and mediated by Gα16, leads to the activation of β-catenin-independent signaling pathway, mainly via activation of ERK5 and PPARγ.</div></div>